B.C. penny stock company from Bridgemark case sues lawyer

  • 📰 BurnabyNOW_News
  • ⏱ Reading Time:
  • 37 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 77%

Business News News

Business Business Latest News,Business Business Headlines

PreveCeutical Medical is blaming its former lawyer for writing a press release that was found to be misleading by a hearing panel at the B.C. Securities Commission; the company was cleared of allegations it breached the Securities Act.

A company that once claimed it was developing technology based on scorpion venom has filed a civil claim against the firm’s former lawyer, claiming he is responsible for a controversial press release found to have contained misrepresentations.

The B.C. Securities Commission dropped its allegations against most of the group but ultimately alleged Preveceutical made misrepresentations in a news release. However, a panel of adjudicators ruled on May 2 that the news release was only misleading and not a misrepresentation in a legal sense, as it did not have a material impact on investors.

“As a result of the defendants’ breach of the standard of care, the plaintiffs have suffered various damages due to, among other things, their exposure to regulatory proceedings arising from the Notice of Hearing and the finding of the British Columbia Securities Commission that the news release and the material change report contained misrepresentations,” the claim states.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 14. in BUSİNESS

Business Business Latest News, Business Business Headlines